// App-Quantinova.ai

: DO WE STILL NEED ANTI-EMBOLISM STOCKINGS? A SYSTEMATIC REVIEW OF THEIR EFFECTIVENESS

Researchers

Presenter

  • Mahmoud Awadallah

Principal Investigators

  • Martyn Parker

  • Sophie Easey

  • Kurinchi Gurusamy

Medical Centers

  • Kings College London, London, United Kingdom

  • North West Anglia NHS Trust, Nephrology, Peterborough, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

Disease

  • Deep vein thrombosis

  • Pulmonary embolism

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Randomized

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A